The Federal Government announced on Tuesday it has signed an agreement with pharmaceutical maker Moderna to start domestic production of mRNA vaccines within our borders.
While a location has yet to be finalized, Moderna will set up a vaccine manufacturing facility in Canada and give access to its mRNA development engine, according to a memorandum of understanding between the company and the government. This will be Massachusetts-based Moderna’s first foreign operation.
“With an mRNA manufacturing facility in our own backyard, we will be much better equipped for the next global health crisis,” said Federal Industry and Innovation Minister Francois-Philippe Champagne during Tuesday’s announcement.
The agreement allows Canada to ask Moderna to shift its production lines to respond to any new or emerging threat. It also includes a research and development component for COVID-19 and a list of other afflictions like flu, heart disease, and cancer.